Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | MLYCD | O95822 | 2/20 | 0.32 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25495435 | 0.87 | GAA (0.36) | CYP1A2ALDH1A1LMNATSHRGAA | |
| SCHEMBL25495423 | 0.87 | GAA (0.36) | CYP1A2ALDH1A1LMNATSHRGAA | |
| SCHEMBL18573883 | 0.85 | CYP1A2 (0.44) | CYP1A2ALDH1A1USP2LMNATSHR | |
| SCHEMBL23960622 | 0.82 | CYP1A2 (0.36) | CYP1A2ALDH1A1USP2LMNATSHR | |
| SCHEMBL23007584 | 0.82 | ALDH1A1 (0.48) | CYP1A2ALDH1A1USP2LMNATSHR | |
| SCHEMBL20855707 | 0.81 | TSHR (0.41) | CYP1A2ALDH1A1USP2LMNATSHR | |
| SCHEMBL466295 | 0.80 | ALDH1A1 (0.56) | CYP1A2ALDH1A1USP2LMNATSHR | |
| Hydrochloric Acid SCHEMBL6578159 | 0.79 | ALDH1A1 (0.55) | CYP1A2ALDH1A1USP2LMNATSHR | |
| SCHEMBL3939164 | 0.78 | OPRM1 (0.40) | CYP1A2ALDH1A1USP2LMNATSHR | |
| SCHEMBL8344819 | 0.78 | CYP1A2 (0.38) | CYP1A2ALDH1A1LMNAGAAMGAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150922-A1 | Fluorinated Derivatives of Gabapentin and Methods of Use Thereof | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-18 | — | — | US | disclosed |
| WO-2021216753-A1 | FLUORINATED DERIVATIVES OF GABAPENTIN AND METHODS OF USE THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2021-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150922-A1 | Fluorinated Derivatives of Gabapentin and Methods of Use Thereof | GABRE, GABBR1, GABRB3 | CYP1A2 1530/4885ALDH1A1 1279/4885USP2 4550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.